Evolving the Pharma Launch Model for a Volatile Global Environment

Authored by:  Jeff Dill – Group President, Innovation & Growth, Ryan Wyrtzen – Partne, Mariah Hanley – Partner, Mindy McGrath – Managing Director, Ryan Anderson – VP of Strategic Accounts

The pharmaceutical launch landscape is becoming increasingly complex. Scientific advances, evolving pricing and market access dynamics, and continued global market volatility are exposing the limitations of traditional, milestone-driven launch models. As launch environments become more dynamic, success depends on an operating model that enables organizations to continuously adapt without losing strategic focus.

What if the future of launch excellence depends not just on a better launch plan, but on a better way of operating?

This white paper explores how a connected launch operating system enables pharma organizations to define strategy earlier, build a culture that embraces adaptation, connect cross-functional teams around shared priorities, and use performance insights to guide faster, more informed decisions. Discover how leading organizations are building more resilient, connected launch capabilities in an increasingly unpredictable world.